|Bid||0.00 x 900|
|Ask||0.00 x 900|
|Day's Range||55.02 - 56.03|
|52 Week Range||49.83 - 89.70|
|Beta (5Y Monthly)||0.59|
|PE Ratio (TTM)||27.59|
|Forward Dividend & Yield||1.16 (2.10%)|
|Ex-Dividend Date||Dec 01, 2022|
|1y Target Est||N/A|
Subscribe to Yahoo Finance Plus to view Fair Value for BAX
DEERFIELD, Ill., November 16, 2022--Baxter International Inc. (NYSE:BAX), a global medtech leader, will present at the 5th Annual Evercore ISI HealthCONx Conference on Thursday, December 1, 2022. Jay Saccaro, Baxter’s chief financial officer, is scheduled to present at 1:00 p.m. Eastern Time.
DEERFIELD, Ill., November 15, 2022--Baxter International Inc. (NYSE:BAX), a global medtech leader, today announced that its Board of Directors has declared a quarterly cash dividend of $0.29 per share of common stock. The dividend is payable on January 3, 2023, to shareholders of record as of December 2, 2022. The indicated annual dividend rate is $1.16 per share of common stock.
Controlled study at 21 hospitals shows remote patient management reduces adverse events for home peritoneal dialysis patientsNew ex vivo study demonstrates superior performance of the Theranova dialyzer in effectively balancing higher removal of large middle-molecule toxins and albumin stability during hemodialysis DEERFIELD, Ill., Nov. 08, 2022 (GLOBE NEWSWIRE) -- Baxter International Inc. (NYSE:BAX), a global innovator in kidney care, advanced scientific exchange with 14 new data presentations